Sellas Life Sciences Stock Analysis
| SLS Stock | USD 1.22 0.02 1.61% |
Sellas Life Sciences is undervalued with Real Value of 2.42 and Target Price of 6.0. The main objective of Sellas Life stock analysis is to determine its intrinsic value, which is an estimate of what Sellas Life Sciences is worth, separate from its market price. There are two main types of Sellas Life's stock analysis: fundamental analysis and technical analysis.
The Sellas Life stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Sellas Life is usually not traded on Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday. Sellas Stock trading window is adjusted to America/New York timezone.
Sellas |
Sellas Stock Analysis Notes
The company recorded a loss per share of 0.67. Sellas Life Sciences last dividend was issued on the 8th of November 2019. The entity had 1:50 split on the 8th of November 2019. SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. The company was founded in 2012 and is headquartered in New York, New York. Sellas Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 11 people. To find out more about Sellas Life Sciences contact the company at 646 200 5278 or learn more at https://www.sellaslifesciences.com.Sellas Life Sciences Investment Alerts
| Sellas Life Sciences generated a negative expected return over the last 90 days | |
| Sellas Life Sciences may become a speculative penny stock | |
| Sellas Life Sciences has high historical volatility and very poor performance | |
| Reported Net Loss for the year was (37.34 M) with profit before taxes, overhead, and interest of 900 K. | |
| Sellas Life Sciences has about 26.99 M in cash with (31.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.31, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Sellas Life Sciences has a frail financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: Highbridge Capital Managements Strategic Acquisition of SELLAS Life Sciences Shares |
Sellas Life Sciences Upcoming and Recent Events
| 21st of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 21st of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Sellas Largest EPS Surprises
Earnings surprises can significantly impact Sellas Life's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-11-07 | 2024-09-30 | -0.1267 | -0.1 | 0.0267 | 21 | ||
2024-08-13 | 2024-06-30 | -0.16 | -0.13 | 0.03 | 18 | ||
2023-08-10 | 2023-06-30 | -0.35 | -0.31 | 0.04 | 11 |
Sellas Life Thematic Classifications
In addition to having Sellas Life stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | BiotechBiotechnology and pharmaceuticals production and services |
Sellas Stock Institutional Investors
Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Springbok Capital Management, Llc | 2024-06-30 | 55.7 K | Lpl Financial Corp | 2024-06-30 | 51.9 K | Mariner Wealth Advisors Llc | 2024-06-30 | 44.9 K | Jane Street Group Llc | 2024-06-30 | 28 K | Charles Schwab Investment Management Inc | 2024-09-30 | 16.2 K | Commonwealth Equity Services Inc | 2024-06-30 | 15.6 K | Wedbush Morgan Securities Inc | 2024-06-30 | 15 K | Calton & Associates, Inc. | 2024-09-30 | 14 K | Tower Research Capital Llc | 2024-06-30 | 13.6 K | Vanguard Group Inc | 2024-09-30 | 2.3 M | Geode Capital Management, Llc | 2024-06-30 | 517 K |
Sellas Market Capitalization
The company currently falls under 'Micro-Cap' category with a total capitalization of 87.27 M.Sellas Profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (8.67) | (9.11) | |
| Return On Capital Employed | 5.04 | 5.29 | |
| Return On Assets | (6.00) | (6.30) | |
| Return On Equity | 4.68 | 4.92 |
Management Efficiency
Sellas Life Sciences has Return on Asset of (1.2915) % which means that on every $100 spent on assets, it lost $1.2915. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (8.8806) %, meaning that it generated no profit with money invested by stockholders. Sellas Life's management efficiency ratios could be used to measure how well Sellas Life manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Sellas Life's Return On Capital Employed is comparatively stable compared to the past year. Return On Equity is likely to gain to 4.92 in 2024, whereas Return On Tangible Assets are likely to drop (9.11) in 2024. At this time, Sellas Life's Intangibles To Total Assets are comparatively stable compared to the past year. Asset Turnover is likely to gain to 0.07 in 2024, whereas Total Assets are likely to drop slightly above 5.9 M in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | (0.29) | (0.27) | |
| Tangible Book Value Per Share | (0.36) | (0.34) | |
| Enterprise Value Over EBITDA | 52.59 | 55.22 | |
| Price Book Value Ratio | (3.69) | (3.51) | |
| Enterprise Value Multiple | 52.59 | 55.22 | |
| Price Fair Value | (3.69) | (3.51) | |
| Enterprise Value | 27.8 M | 26.4 M |
The decision-making processes within Sellas Life are key to its success in a competitive market. By evaluating these processes, we assess the stock's potential for future gains.
Beta 2.396 | Return On Assets (1.29) | Return On Equity (8.88) |
Technical Drivers
As of the 22nd of November, Sellas Life has the Variance of 9.26, insignificant risk adjusted performance, and Coefficient Of Variation of (7,907). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Sellas Life Sciences, as well as the relationship between them. Please validate Sellas Life Sciences information ratio and kurtosis to decide if Sellas Life is priced more or less accurately, providing market reflects its prevalent price of 1.22 per share. Given that Sellas Life Sciences is a hitting penny stock territory we recommend to closely look at its jensen alpha.Sellas Life Sciences Price Movement Analysis
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Sellas Life middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Sellas Life Sciences. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Sellas Life Sciences Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Sellas Life insiders, such as employees or executives, is commonly permitted as long as it does not rely on Sellas Life's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Sellas Life insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Kalin Katherine Bach over three months ago Acquisition by Kalin Katherine Bach of 19000 shares of Sellas Life subject to Rule 16b-3 | ||
Cicic Dragan over three months ago Disposition of 35000 shares by Cicic Dragan of Sellas Life at 1.89 subject to Rule 16b-3 | ||
Cicic Dragan over three months ago Disposition of 65000 shares by Cicic Dragan of Sellas Life at 0.5195 subject to Rule 16b-3 | ||
Jane Wasman over six months ago Acquisition by Jane Wasman of 25000 shares of Sellas Life at 1.38 subject to Rule 16b-3 | ||
Angelos Stergiou over six months ago Acquisition or disposition of Sellas Life securities by Angelos Stergiou | ||
Angelos Stergiou over a year ago Acquisition by Angelos Stergiou of 70000 shares of Sellas Life subject to Rule 16b-3 | ||
Angelos Stergiou over a year ago Acquisition by Angelos Stergiou of 450135 shares of Sellas Life subject to Rule 16b-3 | ||
Angelos Stergiou over a year ago Acquisition by Angelos Stergiou of 58000 shares of Sellas Life subject to Rule 16b-3 |
Sellas Life Outstanding Bonds
Sellas Life issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Sellas Life Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Sellas bonds can be classified according to their maturity, which is the date when Sellas Life Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Sellas Life Predictive Daily Indicators
Sellas Life intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Sellas Life stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Sellas Life Forecast Models
Sellas Life's time-series forecasting models are one of many Sellas Life's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Sellas Life's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Sellas Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Sellas Life prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Sellas shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Sellas Life. By using and applying Sellas Stock analysis, traders can create a robust methodology for identifying Sellas entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (47.50) | (45.12) | |
| Operating Profit Margin | (48.24) | (45.83) | |
| Net Loss | (46.75) | (44.41) | |
| Gross Profit Margin | 0.81 | 0.70 |
Current Sellas Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Sellas analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Sellas analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Advice | # of Analysts | |
| 6.0 | Strong Buy | 3 | Odds |
Most Sellas analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Sellas stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Sellas Life Sciences, talking to its executives and customers, or listening to Sellas conference calls.
Sellas Stock Analysis Indicators
Sellas Life Sciences stock analysis indicators help investors evaluate how Sellas Life stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Sellas Life shares will generate the highest return on investment. By understating and applying Sellas Life stock analysis, traders can identify Sellas Life position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 17.2 M | |
| Total Stockholder Equity | -8 M | |
| Capital Lease Obligations | 906 K | |
| Property Plant And Equipment Net | 858 K | |
| Cash And Short Term Investments | 2.5 M | |
| Net Invested Capital | -8 M | |
| Cash | 2.5 M | |
| 200 Day M A | 1.2291 | |
| 50 Day M A | 1.2312 | |
| Net Interest Income | 642 K | |
| Total Current Liabilities | 13.7 M | |
| Investments | -5.5 M | |
| Stock Based Compensation | 1.4 M | |
| Common Stock Shares Outstanding | 27.8 M | |
| Free Cash Flow | -36.9 M | |
| Operating Income | -37.9 M | |
| Other Current Assets | 642 K | |
| Accounts Payable | 5.6 M | |
| Net Debt | -1.6 M | |
| Other Operating Expenses | 37.9 M | |
| Non Current Assets Total | 3 M | |
| Liabilities And Stockholders Equity | 6.2 M | |
| Home Category | Domestic | |
| Non Currrent Assets Other | 375 K |
Additional Tools for Sellas Stock Analysis
When running Sellas Life's price analysis, check to measure Sellas Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sellas Life is operating at the current time. Most of Sellas Life's value examination focuses on studying past and present price action to predict the probability of Sellas Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sellas Life's price. Additionally, you may evaluate how the addition of Sellas Life to your portfolios can decrease your overall portfolio volatility.